These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8868095)

  • 61. The role of hematopoietic stem cell transplantation in the treatment of multiple myeloma.
    Bensinger WI
    J Natl Compr Canc Netw; 2004 Jul; 2(4):371-8. PubMed ID: 19795599
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Intensive treatment of multiple myeloma].
    Harousseau JL
    Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Current and future approaches to therapy for multiple myeloma].
    Nara N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.
    Hovenga S; de Wolf JT; Guikema JE; Klip H; Smit JW; Smit Sibinga CT; Bos NA; Vellenga E
    Bone Marrow Transplant; 2000 Apr; 25(7):723-8. PubMed ID: 10745257
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.
    Child JA; Morgan GJ; Davies FE; Owen RG; Bell SE; Hawkins K; Brown J; Drayson MT; Selby PJ;
    N Engl J Med; 2003 May; 348(19):1875-83. PubMed ID: 12736280
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multiple myeloma: an update on biology and treatment.
    Ludwig H; Meran J; Zojer N
    Ann Oncol; 1999; 10 Suppl 6():31-43. PubMed ID: 10676551
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Marrow transplantation for myeloma.
    Fermand JP; Brouet JC
    Annu Rev Med; 1995; 46():299-307. PubMed ID: 7598466
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for multiple myeloma].
    Kosugi H
    Rinsho Ketsueki; 2015 Mar; 56(3):279-88. PubMed ID: 25876781
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A negative-selection strategy for depleting myeloma cells from patients' BM and/or leukapheresis blood.
    Louis SA; Zapf R; Clarke E; Thomas TE; Sutherland HJ
    Cytotherapy; 2001; 3(6):489-504. PubMed ID: 11953033
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma.
    Siddiqui M; Gertz M
    Leuk Lymphoma; 2008 Aug; 49(8):1436-51. PubMed ID: 18608872
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.
    Ballester OF; Tummala R; Janssen WE; Fields KK; Hiemenz JW; Goldstein SC; Perkins JB; Sullivan DM; Rosen R; Sackstein R; Zorsky P; Saez R; Elfenbein GJ
    Bone Marrow Transplant; 1997 Oct; 20(8):653-6. PubMed ID: 9383228
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
    Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recent progress in multiple myeloma.
    Moscinski LC; Ballester OF
    Hematol Oncol; 1994; 12(3):111-23. PubMed ID: 7525447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The therapy of multiple myeloma with the interferons.
    Bonnem EM
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():35-41. PubMed ID: 2449280
    [No Abstract]   [Full Text] [Related]  

  • 77. Prolonged survival in resistant myeloma after treatment with interferon--a case report and review.
    Edwards DR
    Hematol Oncol; 1991; 9(1):1-7. PubMed ID: 1710594
    [No Abstract]   [Full Text] [Related]  

  • 78. Gene therapy approaches for multiple myeloma.
    Russell SJ; Dunbar CE
    Semin Hematol; 2001 Jul; 38(3):268-75. PubMed ID: 11486315
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Skin dissemination of myeloma.
    Męcińska-Jundziłł K; Białecka A; Adamska U; Cichewicz A; Skórczewska A; Szukalski J; Czyż J; Jundziłł A; Czajkowski R
    Postepy Dermatol Alergol; 2017 Dec; 34(6):622-624. PubMed ID: 29422830
    [No Abstract]   [Full Text] [Related]  

  • 80. Biology and treatment of myeloma.
    Greipp PR; Witzig T
    Curr Opin Oncol; 1996 Jan; 8(1):20-7. PubMed ID: 8868095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.